Open AccessA randomized multicenter phase II trial of mecapegfilgrastim single administration versus granulocyte colony-stimulating growth factor on treating chemotherapy-induced neutropenia in breast cancer patients
Author(s) -
Tao Wang,
Biao Wu,
Xichun Hu,
Jinping Liu,
Tao Zhang,
Funian Li,
Bing Sun,
Li Cai,
Xinzheng Li,
Zhiyue Chen,
Qing Yang,
Zefei Jiang
Publication year - 2019
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm.2019.04.10
Subject(s) - neutropenia , medicine , febrile neutropenia , chemotherapy , granulocyte colony stimulating factor , breast cancer , incidence (geometry) , adverse effect , clinical endpoint , gastroenterology , randomized controlled trial , oncology , cancer , physics , optics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom